Scheriproct Ointment contains the active ingredients Cinchocaine Hydrochloride and Prednisolone Hexanoate. It is used to treat haemorrhoids (piles). Scheriproct is classified as a Prescription-only-medicine (POM) and is manufactured by Valeant Pharmaceuticals. Scheriproct Ointment comes in a 30g tube, which includes an attachable plastic applicator and a detailed patient information leaflet (PIL).
Cinchocaine belongs to a group of medicines called local anaesthetics. These medicines work by blocking the pain messages along the nerve fibers. This prevents the pain signals from reaching the brain, creating a numbing sensation in the area where the ointment has been absorbed. When treating piles, using a local anaesthetic such as Cinchocaine will numb the affected area, reducing the pain and itching associated with haemorrhoids.
The other active ingredient, Prednisolone belongs to a category of medicines known as; Corticosteroids. These medicines work to relieve pain and inflammation. Inflammation is caused by an immune response that causes blood vessels to dilate (widen), resulting in the affected area becoming red, painful, itchy and swollen. Prednisolone works from within the cell. It actively reduces the substances produced by the body that trigger the inflammation. When Prednisolone is used to treat Haemorrhoids, it will effectively reduce the painful inflammation and swelling caused by this condition.
Scheriproct Ointment is designed for short-term relief from the symptoms of haemorrhoids and anal itching. This is usually between five and seven days. It is not recommended to use Scheriproct for longer than seven days, unless advised to by a doctor or specialist. Scheriproct Ointment is suitable to treat both external and internal haemorrhoids. It can be applied directly to the anal area to relieve external piles. Alternatively, through use of the attachable applicator, it can be gently inserted into the rectum in order to relieve internal piles. If your haemorrhoids are exclusively internal then suppositories, such as Anusol HC, may be more appropriate for treatment.
Always wash your hands before and after applying Scheriproct. Do not use Scheriproct Ointment for more than 7 days.
How to use Scheriproct Ointment:
Scheriproct Ointment should be appiled in the morning, at night, and after each bowel movement for up to 7 days.
Before you use Scheriproct, gently but thoroughly wash and dry the anus (back passage) and the skin around it.
If the ointment is to be used for the area around the anus:
Squeeze a small quantity (about the size of a pea) on to the top of your finger.
Spread it gently over the skin and just inside the anus.
Do not rub it in.
If the ointment is to be used inside the anus:
Put the separate nozzle (applicator) onto the tube.
Squeeze the tube until the nozzle is full of ointment. The amount of ointment in the nozzle is one dose.
Insert the nozzle very carefully into the anus until the whole length of the nozzle is inside. Then, while squeezing the tube gently, withdraw the nozzle.
Wash the nozzle carefully in hot soapy water and rinse thoroughly.
Like all medicines, Scheriproct can cause side effects, although not everybody gets them.
Some thinning of the skin may occur if too much Scheriproct is applied for long periods of time (much longer than 5 to 7 days).
Allergic skin reactions may occur in rare cases. Castor oil, one of the ingredients of Scheriproct Ointment may cause a skin reaction.
If you experience any of these side effects and this becomes serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Do not use Scheriproct if you:
are allergic (hypersensitive) to prednisolone hexanoate, cinchocaine hydrochloride, other local anaesthetics or any of the other ingredients of Scheriproct.
have a viral infection (e.g. herpes, shingles, chicken-pox)
have any bacterial or fungal infections of the skin or elsewhere for which you are not receiving treatment.
Take special care with Scheriproct
Long-term continuous treatment should be avoided because it increases the possibility of side effects. This is particularly important for infants and small children because continuous treatment with Scheriproct for long periods may reduce the activity of the adrenal glands and so lower resistance to disease. Also, long-term treatment can cause the skin to thin and deteriorate in the affected area and some of the medicine may be absorbed into the blood stream.
If the area treated with Scheriproct is also infected your doctor should prescribe another medicine, to use with Scheriproct, to treat the infection.
Do not use a waterproof dressing to cover areas where you have applied the cream.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Pregnancy and breast-feeding
You should not order Scheriproct online if you are, or may be, pregnant or breastfeeding. You should instead contact your doctor or midwife for advice before using this medicine. There may be a very small risk to the development of a baby in pregnant women treated with Scheriproct. As with most medicines, this risk is likely to be greatest during the first 3 months of pregnancy.
Driving and using machines
Scheriproct has no influence on the ability to drive and use machines.
The active substances are prednisolone hexanoate and cinchocaine hydrochloride. 1 g of Scheriproct Ointment contains 1.9 mg prednisolone hexanoate and 5.0 mg cinchocaine hydrochloride
The other ingredients are polyethylene glycol 400 monoricinoleate, hydrogenated castor oil, castor oil, 2 octyldodecanol, chypre perfume oil.